申请人:Bayer Aktiengesellschaft
公开号:EP3858986A1
公开(公告)日:2021-08-04
The present invention relates to novel recombinant Bacillus megaterium cytochrome P450-monooxygenase (P450-BM3) variants for the C19 hydroxylation of steroids and derivatives thereof. In particular, the present invention also relates to methods and processes using P450-BM3 variants for the production of estrone and estradiol. The invention further relates to nucleotide sequences, constructs and vectors for the expression of these P450-BM3 variants
本发明涉及新型重组巨芽孢杆菌细胞色素 P450-单加氧酶(P450-BM3)变体,用于类固醇及其衍生物的 C19 羟基化。特别是,本发明还涉及使用 P450-BM3 变体生产雌酮和雌二醇的方法和工艺。本发明还涉及用于表达这些 P450-BM3 变体的核苷酸序列、构建体和载体